{"id":"https://openalex.org/W2039437847","doi":"https://doi.org/10.1093/jac/36.4.657","title":"Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia","display_name":"Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia","alternate_titles":[],"publication_year":1995,"publication_date":"1995-10-01","ids":{"openalex":"https://openalex.org/W2039437847","doi":"https://doi.org/10.1093/jac/36.4.657","mag":"2039437847","pmid":"https://pubmed.ncbi.nlm.nih.gov/8591940"},"language":"en","primary_location":{"id":"doi:10.1093/jac/36.4.657","doi":"https://doi.org/10.1093/jac/36.4.657","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/36.4.657","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2039437847"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111975794","display_name":"Archibald Grant Prentice","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802723752","display_name":"Derriford Hospital","ror":"https://ror.org/00v5h4y49","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802723752","https://openalex.org/I4210166818"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Archibald G. Prentice","raw_affiliation_strings":["Department of Haematology, Derriford Hospital, Plymouth, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Haematology, Derriford Hospital, Plymouth, UK","institution_ids":["https://openalex.org/I2802723752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037841398","display_name":"David W. Warnock","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802723752","display_name":"Derriford Hospital","ror":"https://ror.org/00v5h4y49","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802723752","https://openalex.org/I4210166818"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David W. Warnock","raw_affiliation_strings":["a Department of Haematology Derriford Hospital, Plymouth PL6 SDH","Department of HaematologyDerriford Hospital, Plymouth PL6 SDH;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"a Department of Haematology Derriford Hospital, Plymouth PL6 SDH","institution_ids":["https://openalex.org/I2802723752"]},{"raw_affiliation_string":"Department of HaematologyDerriford Hospital, Plymouth PL6 SDH;","institution_ids":["https://openalex.org/I2802723752"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055768833","display_name":"Stephen A. Johnson","orcid":"https://orcid.org/0000-0002-9058-4331","observed_orcids":["https://orcid.org/0000-0002-9058-4331"]},"institutions":[{"id":"https://openalex.org/I2800820451","display_name":"Musgrove Park Hospital","ror":"https://ror.org/042fv2404","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800820451"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Stephen A. N. Johnson","raw_affiliation_strings":["c Department of Haematology Musgrove Park Hospital, Taunton TA1 5DB","Department of HaematologyMusgrove Park Hospital, Taunton TA1 5DB;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"c Department of Haematology Musgrove Park Hospital, Taunton TA1 5DB","institution_ids":["https://openalex.org/I2800820451"]},{"raw_affiliation_string":"Department of HaematologyMusgrove Park Hospital, Taunton TA1 5DB;","institution_ids":["https://openalex.org/I2800820451"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Peter C. Taylor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093108","display_name":"Rotherham General Hospital","ror":"https://ror.org/00gw6hy83","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210093108","https://openalex.org/I4210101025"]},{"id":"https://openalex.org/I4210101025","display_name":"The Rotherham NHS Foundation Trust","ror":"https://ror.org/00z4t3785","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210101025"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter C. Taylor","raw_affiliation_strings":["d Department of Haematology Rotherham District General Hospital, Rotherham S602UD, UK","Department of HaematologyRotherham District General Hospital, Rotherham S602UD, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"d Department of Haematology Rotherham District General Hospital, Rotherham S602UD, UK","institution_ids":["https://openalex.org/I4210093108","https://openalex.org/I4210101025"]},{"raw_affiliation_string":"Department of HaematologyRotherham District General Hospital, Rotherham S602UD, UK","institution_ids":["https://openalex.org/I4210093108","https://openalex.org/I4210101025"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5104005135","display_name":"Debra Oliver","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Debra A. Oliver","raw_affiliation_strings":["b PHLS Mycology Reference Laboratory Public Health Laboratory, Bristol BS2 8EL","PHLS Mycology Reference LaboratoryPublic Health Laboratory, Bristol BS2 8EL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"b PHLS Mycology Reference Laboratory Public Health Laboratory, Bristol BS2 8EL","institution_ids":[]},{"raw_affiliation_string":"PHLS Mycology Reference LaboratoryPublic Health Laboratory, Bristol BS2 8EL;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5037841398"],"corresponding_institution_ids":["https://openalex.org/I2802723752"],"apc_list":{"value":2869,"currency":"GBP","value_usd":3784},"apc_paid":null,"fwci":3.4335,"has_fulltext":false,"cited_by_count":78,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.91851642,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"36","issue":"4","first_page":"657","last_page":"663"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/itraconazole","display_name":"itraconazole","score":1.0},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8240000009536743},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8980000019073486},{"id":"https://openalex.org/keywords/chemotherapy","display_name":"chemotherapy","score":0.5249999761581421},{"id":"https://openalex.org/keywords/antifungal-prophylaxis","display_name":"antifungal prophylaxis","score":0.9229999780654907},{"id":"https://openalex.org/keywords/oral-solution","display_name":"oral solution","score":0.8389999866485596},{"id":"https://openalex.org/keywords/dosing-regimen","display_name":"dosing regimen","score":0.45100000500679016},{"id":"https://openalex.org/keywords/serum-drug-levels","display_name":"serum drug concentration","score":0.5640000104904175},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.7350000143051147},{"id":"https://openalex.org/keywords/induction-chemotherapy","display_name":"induction chemotherapy","score":0.6309999823570251}],"concepts":[{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.9855820536613464},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8001632690429688},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7178035974502563},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.6822237968444824},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48201289772987366},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.4393143653869629},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.42728540301322937},{"id":"https://openalex.org/C2779282312","wikidata":"https://www.wikidata.org/wiki/Q1956561","display_name":"Myeloid","level":2,"score":0.42305922508239746},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39010390639305115},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.33719736337661743},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009181","descriptor_name":"Mycoses","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D015479","descriptor_name":"Leukemia, Myelomonocytic, Acute","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015479","descriptor_name":"Leukemia, Myelomonocytic, Acute","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015479","descriptor_name":"Leukemia, Myelomonocytic, Acute","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016867","descriptor_name":"Immunocompromised Host","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1093/jac/36.4.657","doi":"https://doi.org/10.1093/jac/36.4.657","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jac/36.4.657","pdf_url":null,"source":{"id":"https://openalex.org/S124275759","display_name":"Journal of Antimicrobial Chemotherapy","issn_l":"0305-7453","issn":["0305-7453","1460-2091"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Antimicrobial Chemotherapy","raw_type":"journal-article"},{"id":"pmid:8591940","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8591940","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of antimicrobial chemotherapy","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":9,"referenced_works":["https://openalex.org/W1970631373","https://openalex.org/W2007921929","https://openalex.org/W2020985135","https://openalex.org/W2039366893","https://openalex.org/W2062992033","https://openalex.org/W2065419430","https://openalex.org/W2070419702","https://openalex.org/W2085792620","https://openalex.org/W2138070714"],"related_works":["https://openalex.org/W1969183015","https://openalex.org/W2016683993","https://openalex.org/W2107471693","https://openalex.org/W2138070714","https://openalex.org/W1966265812","https://openalex.org/W2114500604","https://openalex.org/W2036557899","https://openalex.org/W2608483838","https://openalex.org/W2069193583","https://openalex.org/W2062992033"],"abstract_inverted_index":{"The":[0,45],"multiple":[1],"dose":[2,48],"pharmacokinetics":[3],"of":[4,7,17,49,69,157],"a":[5],"solution":[6,156],"itraconazole":[8,31,50,90,105,134,160],"given":[9,30],"orally":[10],"were":[11,29,74,95,119,136],"measured":[12],"in":[13,62,79,123,129,165,174],"an":[14,154],"open":[15],"study":[16],"20":[18],"patients":[19,55,63,80,124,175],"undergoing":[20],"remission":[21],"induction":[22],"chemotherapy":[23,177],"for":[24,54,98,171,178],"acute":[25,179],"myeloid":[26,180],"leukaemia.":[27,181],"Patients":[28],"5":[32,57,83,126,158],"mg/kg":[33,36,39,43,88,103,159],"od,":[34],"2.5":[35,38,65,87,102,132],"bd,":[37],"od":[40,85,104],"or":[41,86,164],"1.25":[42],"bd.":[44],"mean":[46,93],"daily":[47,163],"was":[51],"407":[52],"mg":[53,61],"receiving":[56,64,125,131,176],"mg/kg/day":[58,127,133],"and":[59,71,135,138],"148":[60],"mg/kg/day.":[66],"Mean":[67,112],"concentrations":[68,94,151],"493":[70],"495":[72],"micrograms/L":[73,108],"achieved":[75],"on":[76,109,141],"day":[77,110,142],"8":[78],"who":[81,100],"received":[82,101],"mg/kg/d":[84],"bd":[89],"respectively.":[91,144],"However,":[92],"significantly":[96],"lower":[97],"those":[99,130],"being":[106],"110":[107],"8.":[111],"areas":[113],"under":[114],"the":[115,149],"serum-concentration":[116],"time":[117],"curves":[118],"also":[120],"markedly":[121],"higher":[122],"than":[128],"22,382":[137],"5615":[139],"micrograms.h/L":[140],"15":[143],"These":[145],"findings":[146],"suggest":[147],"that":[148],"serum":[150],"attained":[152],"with":[153],"oral":[155],"either":[161],"once":[162],"two":[166],"divided":[167],"doses":[168],"are":[169],"suitable":[170],"antifungal":[172],"prophylaxis":[173]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2039437847","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
